Prolactin and Primary Antiphospholipid Syndrome
Author Information
Author(s): Manoel Tavares Neves Junior, Carlos Ewerton Maia Rodrigues, Jozelio Freire de Carvalho
Primary Institution: Faculdade de Medicina, Universidade de Sao Paulo
Hypothesis
Does prolactin play a role in primary antiphospholipid syndrome?
Conclusion
The study found that prolactin levels are similar in patients with primary antiphospholipid syndrome and healthy controls, suggesting it does not play a significant role in the syndrome's clinical manifestations.
Supporting Evidence
- Prolactin levels were similar between pAPS patients and healthy controls.
- 9% of pAPS patients and 12.1% of controls had hyperprolactinemia.
- No significant clinical differences were found between hyperprolactinemic and normoprolactinemic pAPS patients.
Takeaway
This study looked at prolactin levels in people with a specific blood condition and found that it doesn't seem to affect their health compared to healthy people.
Methodology
A case-control study comparing prolactin levels and clinical data between 55 patients with primary antiphospholipid syndrome and 41 healthy controls.
Potential Biases
Potential biases due to exclusion of patients with other autoimmune diseases and those on medications affecting prolactin levels.
Limitations
Serum prolactin levels were only measured at a single time point, which may have missed variations in hormone secretion.
Participant Demographics
55 patients with primary antiphospholipid syndrome, age- and sex-matched with 41 healthy controls, predominantly female and Caucasian.
Statistical Information
P-Value
0.876
Statistical Significance
p > 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website